Understanding Prostate Cancer Risk Factors: Insights from Ajay Dar, MD

September is Prostate Cancer Awareness Month and prostate cancer remains one of the most prevalent cancers affecting men today. While having risk factors does not guarantee that you will develop the disease, being aware of these factors can help you take proactive steps in managing your health. Dr. Ajay Dar from Virginia Cancer Specialists sheds […]
Breakthrough Targeted Therapy Shows Promise for KRAS-Mutated Pancreatic Cancer, with Virginia Cancer Specialists and NEXT Oncology Playing Key Role

FOR IMMEDIATE RELEASE Breakthrough Targeted Therapy Shows Promise for KRAS-Mutated Pancreatic Cancer, with Virginia Cancer Specialists and NEXT Oncology Playing Key Role Fairfax, VA — May 12, 2026 — Virginia Cancer Specialists announced today its participation as a leading clinical trial site in a landmark study evaluating daraxonrasib, a first-in-class targeted oral therapy for patients […]
New OncoTalks Episode: Advancing Biomarker Testing in NSCLC – Dr. Alexander I. Spira, MD, PhD, FACP, FASCO

Virginia Cancer Specialists is pleased to share a new episode of OncoTalks featuring our own Dr. Alexander I. Spira, MD, PhD, FACP, FASCO—Co-Director of the Virginia Cancer Specialists Research Institute and Director of the Thoracic and Phase I Program. In this episode, host Dr. Ira Zackon joins Dr. Spira for an in-depth discussion on the […]
Bringing Advanced Cancer Care Closer to Home at Reston Hospital

For patients facing cancer, access to advanced care close to home can make a powerful difference. In a recent video interview filmed at Reston Hospital, Dr. Christina Brzezniak and Dr. Mitul Gandhi discuss why community-based cancer care—including access to the latest therapies—is so important for patients and their families. Dr. Brzezniak brings light to Reston […]
Improved Survival with a Chemotherapy Free Option for EGFR Mutated Lung Cancer

Living with advanced non–small cell lung cancer (NSCLC) driven by mutations in the EGFR gene can feel overwhelming. For many patients, treatment has meant targeted therapy with the gold standard osimertinib, an oral targeted therapy directed toward the EGFR mutated tumor cells. Data from the large MARIPOSA trial published in September 2025 in The New […]
Join the Virginia Cancer Specialists Team at the 2025 Multiple Myeloma Research Foundation Walk/Run

JOIN US! Virginia Cancer Specialists is proud to participate in the 2025 Multiple Myeloma Research Foundation Walk/Run, and we want YOU on our team! When: Saturday, September 27 Where: The Wharf | Washington, D.C. Time: Event opens at 8:00 AM | Program begins at 8:20 AM | Walk/Run: 9:00–10:15 AM We’re honored to have Dipti […]
Research is Hope. Hope for Today. Hope for Tomorrow.

At Virginia Cancer Specialists, research isn’t just a part of what we do — it’s the cornerstone of our mission to provide the best available care for every patient. With +200 active clinical trials across Phase 1-3, we’re proud to offer patients access to innovative investigational therapies – often unavailable to the general public. From […]
New Treatment Breakthrough: Amivantamab Plus Lazertinib for Advanced Lung Cancer – Timothy A. McCarthy, MD

A groundbreaking study published in June 2024 in The New England Journal of Medicine has introduced a promising new treatment for a specific type of advanced lung cancer. The research, co-authored by Alex Spira, MD, PhD, FACP, FACSO, Medical Oncologist and Co-Director of The Virginia Cancer Specialists Research Institute, highlights the combination of two drugs, […]
Multiple Myeloma Research Foundation (MMRF) Walk/Run: Washington D.C. September 28, 2024

MMRF Walk/Run: Washington D.C. September 28, 2024 Register with Team Virginia Cancer Specialists Today! Honorary Event Chair Dipti Patel Donnelly, MD For over 25 years, the MMRF has been the leading cancer research organization focused on multiple myeloma, the second most common blood cancer. When you sign up for an MMRF Walk/Run event, you join […]
Unlocking Hope: Celebrating Clinical Trials Week with Virginia Cancer Specialists

As we celebrate Clinical Trials Week, we honor the remarkable journey of discovery and innovation that clinical trials represent in the realm of cancer research. At Virginia Cancer Specialists, we stand as a beacon of hope, leading the charge in pioneering breakthrough treatments and shaping the future of oncology care. A Legacy of Excellence: […]